Editorial: Community series in unveiling the tumor microenvironment by machine learning to develop new immunotherapeutic strategies, volume II

Editorial: Community series in unveiling the tumor microenvironment by machine learning to develop new immunotherapeutic strategies, volume II

Bibliographic Details
Main Authors:	Ping Zheng, Jun Liu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-01-01
Series:	Frontiers in Immunology
Subjects:	tumor microenvironment machine learning tumor disease immune infiltrations
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1351597/full

Similar Items

Editorial: Unveiling the tumor microenvironment by machine learning to develop new immunotherapeutic strategies
by: Ping Zheng, et al.
Published: (2023-08-01)

Tumor immune microenvironment (TIME) to enhance antitumor immunity
by: Sajin Rajbhandary, et al.
Published: (2023-05-01)

Editorial: Tumor microenvironment immunophenotypes and disease progression
by: Ana Carolina Monteiro, et al.
Published: (2023-01-01)

Editorial: Community series in the role of angiogenesis and immune response in tumor microenvironment of solid tumor: volume II
by: Haosheng Li, et al.
Published: (2023-11-01)

Editorial: The role of angiogenesis and immune response in tumor microenvironment of solid tumor
by: Zichao Guo, et al.
Published: (2023-04-01)

Identifying the tumor immune microenvironment-associated prognostic genes for prostate cancer
by: Shi Zong, et al.
Published: (2024-02-01)

A Bloody Conspiracy— Blood Vessels and Immune Cells in the Tumor Microenvironment
by: Lisa Terrassoux, et al.
Published: (2022-09-01)

Editorial: Community series in novel insights into immunotherapy targeting tumor microenvironment in ovarian cancer: volume II
by: An Tong, et al.
Published: (2023-11-01)

Editorial: Community series in novel insights into immunotherapy targeting tumor microenvironment in ovarian cancer: volume I
by: Xiang-jie Di, et al.
Published: (2023-04-01)

Editorial: Complexity of tumor microenvironment: A major culprit in cancer development
by: Ihtisham Bukhari, et al.
Published: (2022-10-01)

Unveiling the Immune Microenvironment’s Role in Breast Cancer: A Glimpse into Promising Frontiers
by: Amalia Kotsifaki, et al.
Published: (2023-10-01)

Editorial: The interconnection between the tumor microenvironment and immunotherapy in brain tumors
by: Chunrun Qu, et al.
Published: (2023-03-01)

Multiple datasets to explore the tumor microenvironment of cutaneous squamous cell carcinoma
by: Jiahua Xing, et al.
Published: (2022-04-01)

Editorial: The role of tumor microenvironment in primary liver cancer therapeutic resistance
by: Zhangya Pu, et al.
Published: (2022-07-01)

The effect of neoadjuvant chemotherapy on the tumor immune microenvironment in gastrointestinal tumors
by: Yujie Wang, et al.
Published: (2022-11-01)

Identification of Immune Cell Infiltration and Immune-Related Genes in the Tumor Microenvironment of Glioblastomas
by: Sicong Huang, et al.
Published: (2020-10-01)

Deciphering the Labyrinthine System of the Immune Microenvironment in Recurrent Glioblastoma: Recent Original Advances and Lessons from Clinical Immunotherapeutic Approaches
by: Elena Anghileri, et al.
Published: (2021-12-01)

Tumor microenvironment-mediated immune tolerance in development and treatment of gastric cancer
by: Yuanda Liu, et al.
Published: (2022-10-01)

The Heterogeneity of Immune Cell Infiltration Landscape and Its Immunotherapeutic Implications in Hepatocellular Carcinoma
by: Yuanyuan Guo, et al.
Published: (2022-03-01)

Immune Microenvironment and Immunotherapeutic Management in Virus-Associated Digestive System Tumors
by: Panagiotis Sarantis, et al.
Published: (2022-11-01)

Editorial: Genomics of immunoregulation and inflammatory responses in the tumor microenvironment
by: Lan Zhao, et al.
Published: (2023-02-01)

Prognostic Gene Expression, Stemness and Immune Microenvironment in Pediatric Tumors
by: David Stahl, et al.
Published: (2021-02-01)

Editorial: Cell network in antitumor immunity of pediatric and adult solid tumors
by: Silvia Pesce, et al.
Published: (2023-07-01)

Immune Landscape of the Tumor Microenvironment Identifies Prognostic Gene Signature CD4/CD68/CSF1R in Osteosarcoma
by: Yi-jiang Song, et al.
Published: (2020-07-01)

Editorial: Modulation of T-cell function and survival by the tumor microenvironment
by: Kristian M. Hargadon, et al.
Published: (2023-08-01)

MYD88 Is a Potential Prognostic Gene and Immune Signature of Tumor Microenvironment for Gliomas
by: Qinglong Guo, et al.
Published: (2021-04-01)

The expression pattern of immune-related genes and characterization of tumor immune microenvironment: predicting prognosis and immunotherapeutic effects in cutaneous melanoma
by: Dong Dong, et al.
Published: (2022-09-01)

LATPS, a novel prognostic signature based on tumor microenvironment of lung adenocarcinoma to better predict survival and immunotherapy response
by: Jihong Huang, et al.
Published: (2022-11-01)

CXCL10 is a Tumor Microenvironment and Immune Infiltration Related Prognostic Biomarker in Pancreatic Adenocarcinoma
by: Huimin Huang, et al.
Published: (2021-02-01)

Unveiling tumor immune evasion mechanisms: abnormal expression of transporters on immune cells in the tumor microenvironment
by: Lu Chen, et al.
Published: (2023-07-01)

Regulation of Ovarian Cancer Prognosis by Immune Cells in the Tumor Microenvironment
by: Maureen L. Drakes, et al.
Published: (2018-09-01)

Prediction and therapeutic targeting of the tumor microenvironment-associated gene CTSK in gastric cancer
by: Zilong Bai, et al.
Published: (2023-11-01)

SAA1 Expression as a Potential Prognostic Marker of the Tumor Microenvironment in Glioblastoma
by: Kangxi Cao, et al.
Published: (2022-06-01)

Tumor Immune Microenvironment Characterization Identifies Prognosis and Immunotherapy-Related Gene Signatures in Melanoma
by: Dan Liu, et al.
Published: (2021-05-01)

SERPINE1 associated with remodeling of the tumor microenvironment in colon cancer progression: a novel therapeutic target
by: Shaokun Wang, et al.
Published: (2021-07-01)

Pan-cancer analysis identifies YTHDF2 as an immunotherapeutic and prognostic biomarker
by: Weiwei Liu, et al.
Published: (2022-08-01)

The pyroptosis-related signature predicts prognosis and influences the tumor immune microenvironment in dedifferentiated liposarcoma
by: Chen Wenjing, et al.
Published: (2024-01-01)

NCAPD2 is a favorable predictor of prognostic and immunotherapeutic biomarker for multiple cancer types including lung cancer
by: Linyuan Feng, et al.
Published: (2024-01-01)

Unveiling the Role of Tumor-Infiltrating T Cells and Immunotherapy in Hepatocellular Carcinoma: A Comprehensive Review
by: Xiaokun Chen, et al.
Published: (2023-10-01)

Immune Cells in the Tumor Microenvironment of Soft Tissue Sarcomas
by: Enar Jumaniyazova, et al.
Published: (2023-12-01)